FDA-approved neurotoxin with 98% purity rate, containing 100 units of Clostridium botulinum type A-haemagglutinin complex. Clinically proven to reduce muscle hyperactivity within 24-48 hours, maintaining therapeutic efficacy for 3-6 months post-injection. Trusted by neurologists and dermatologists worldwide for its pharmaceutical-grade stability and predictable diffusion pattern.

Therapeutic Advantages

Proprietary Purification Technology

Clinical Protocol

Pharmaceutical Specifications

Medical Notice: Results may vary ±20% based on patient’s neuromuscular status and injection technique. Must be administered by licensed practitioners only. Contraindicated in patients with aminoglycoside hypersensitivity or myasthenic disorders. Not for general distribution – keep refrigerated at all times.